Stocks HLP Financial statements
Financial statementsHongli Group Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Hongli Group Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Revenue | 11.2 | 21.7 | 20.3 | 16 | 14.1 | 19.6 |
| Cost of revenue | 6.71 | 14.1 | 13.3 | 10.8 | 9.59 | 13.2 |
| Gross profit | 4.45 | 7.65 | 7.01 | 5.25 | 4.52 | 6.38 |
| Research and development | 0.64 | 1.47 | 1.41 | 0.96 | 0.82 | 0.99 |
| Selling, general and administrative | 1.98 | 3.72 | 4.09 | 4.23 | 6.1 | |
| Selling and marketing | 0.29 | 0.64 | 0.6 | 0.63 | 0.67 | 0.94 |
| General and administrative | 2.63 | 4.62 | 2.02 | |||
| Operating expenses | 1.98 | 3.72 | 4.09 | 4.23 | 6.1 | 3.95 |
| Operating income | 2.47 | 3.94 | 2.92 | 1.02 | -1.58 | 2.43 |
| Interest expense | 0.26 | 0.31 | 0.37 | 0.65 | 0.16 | 0.17 |
| Other non-operating income | 0.19 | -0.47 | 0.29 | -0.09 | -0.29 | -0.26 |
| Pre-tax income | 2.66 | 3.47 | 3.21 | 0.93 | -1.87 | 2.17 |
| Income tax | 0.24 | 0.26 | 0.28 | 0.07 | 0.01 | 0.23 |
| Net income | 2.42 | 3.2 | 2.93 | 0.86 | -1.88 | 1.94 |
| EBITDA | 2.99 | 4.52 | 3.57 | 1.89 | -0.78 | 3.12 |
| EPS, basic | 0.24 | 0.32 | 0.29 | 0.07 | -0.11 | 0.03 |
| EPS, diluted | 0.24 | 0.32 | 0.29 | 0.07 | -0.11 | 0.03 |
| Shares, basic (weighted) | 10 | 10 | 10 | 11.8 | 17.5 | 73.4 |
| Shares, diluted (weighted) | 10 | 10 | 10 | 11.8 | 17.5 | 73.4 |
Balance sheet
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Cash and equivalents | 1.43 | 0.48 | 2.09 | 0.78 | 0.91 | 1.81 |
| Receivables | 5.01 | 7.43 | 6.01 | 5.81 | 9.27 | |
| Inventory | 2.97 | 2.61 | 2.35 | 2.67 | 2.46 | |
| Other current assets | 0.11 | 0.07 | 0.03 | 0.01 | 0.11 | |
| Total current assets | 11.4 | 14.1 | 10.8 | 11.9 | 16.1 | |
| Property, plant and equipment | 4.62 | 12.3 | 10.8 | 10.4 | 12.3 | |
| Intangible assets | 0.72 | 4.96 | 4.66 | 4.43 | 4.5 | |
| Other non-current assets | 0.09 | 0 | ||||
| Total assets | 21.8 | 36.2 | 32.1 | 65 | 72.2 | |
| Accounts payable | 2.45 | 2.96 | 1.38 | 1.38 | 1.88 | |
| Accrued liabilities | 0.19 | 0.13 | 0.29 | 0.25 | ||
| Deferred revenue | 0.06 | 0.18 | 0.22 | 0.16 | ||
| Short-term debt | 5.66 | 10.1 | 0.04 | 0.24 | 3.41 | |
| Total current liabilities | 9.69 | 12.4 | 7.68 | 8.21 | 14.4 | |
| Long-term debt | 0.38 | 0.04 | 3.34 | |||
| Total liabilities | 10.4 | 22.7 | 11 | 11.5 | 14.4 | |
| Total debt | 10.1 | 3.37 | 3.55 | |||
| Paid-in capital | 0.61 | 0.61 | 8.04 | 43 | 43 | |
| Retained earnings | 9.81 | 12.7 | 13.6 | 11.7 | 13.7 | |
| Other comprehensive income | 0.7 | -0.25 | -0.91 | -1.61 | 0.79 | |
| Shareholders' equity | 8.04 | 11.5 | 13.5 | 21.1 | 53.5 | 57.8 |
| Total equity | 8.04 | 11.5 | 13.5 | 21.1 | 53.5 | 57.8 |
| Total liabilities and equity | 21.8 | 36.2 | 32.1 | 65 | 72.2 | |
| Shares outstanding | 10 | 10 | 12.2 | 73.4 | 73.4 |
Cash flow statement
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Net income | 2.42 | 3.2 | 2.93 | 0.86 | -1.88 | 1.94 |
| Depreciation and amortization | 0.52 | 0.59 | 0.64 | 0.87 | 0.8 | 0.69 |
| Stock-based compensation | 1.97 | |||||
| Deferred income tax | 0.02 | -0.03 | -0.03 | -0.02 | ||
| Change in receivables | -0.62 | -1.84 | -2.88 | 1.16 | 0 | -3.25 |
| Change in inventory | -0.45 | -1.46 | 0.1 | 0.16 | -0.39 | 0.19 |
| Change in payables | 0.39 | 1.4 | 0.52 | -1.56 | 0.04 | 0.44 |
| Cash from operations | 2.98 | 1.14 | 2.49 | 0.88 | -0.41 | 0.88 |
| Capital expenditures | -0.58 | -1 | -5.1 | -0.3 | -0.03 | -0.22 |
| Acquisitions | 1.49 | |||||
| Purchases of investments | -33.4 | |||||
| Sales and maturities of investments | 1.49 | |||||
| Cash from investing | -2.01 | -3.05 | -11.7 | -2.25 | -33.3 | -1.26 |
| Debt issued | 10.4 | |||||
| Stock issued | 1.14 | |||||
| Cash from financing | 0.11 | 0.98 | 10.8 | 0.38 | 33.5 | 1.26 |
| Exchange rate effect | 0.08 | 0.03 | -0.08 | -0.31 | 0.33 | 0.09 |
| Net change in cash | 1.15 | -0.9 | 1.58 | -1.3 | 0.11 | 0.96 |
| Free cash flow | 2.39 | 0.13 | -2.61 | 0.58 | -0.45 | 0.66 |
| Interest paid | 0.37 | 0.65 | 0.6 | 0.35 | ||
| Income taxes paid | -0.24 | -0.26 | -0.28 | -0.07 | -0.01 | 0.09 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 32.5% | Gross profit / revenue. |
| Operating margin | 12.4% | Operating income / revenue. |
| EBITDA margin | 15.9% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 11.1% | Pre-tax income / revenue. |
| Net margin | 9.9% | Net income / revenue. |
| FCF margin | 3.4% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 4.5% | Cash from operations / revenue. |
| Effective tax rate | 10.5% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 3.5% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 2.8% | Net income / average total assets. |
| Return on invested capital (ROIC) | 3.9% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 5.1% | Research and development expense / revenue. |
| Capex / revenue | 1.1% | Capital expenditures / revenue. |
| D&A / revenue | 3.5% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 39.0% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | -1.1% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 11.9% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 41.1% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | -3.1% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 7.5% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income CAGR, 3y | -5.9% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income CAGR, 5y | -0.3% | Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EBITDA CAGR, 3y | -4.4% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | 0.9% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income CAGR, 3y | -12.8% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income CAGR, 5y | -4.3% | Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EPS CAGR, 3y | -53.1% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS CAGR, 5y | -34.0% | Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 3y | -29.4% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | -21.7% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow CAGR, 5y | -22.7% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | 8.1% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 62.5% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 48.4% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 11.0% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 25.9% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Share count change, 1y | 320.8% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 94.4% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 49.0% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.12x | Current assets / current liabilities. |
| Quick ratio | 0.77x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.13x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 19.9% | Total liabilities / total assets. |
| Interest coverage | 14.7x | Operating income / interest expense. |
| Working capital | $1.7M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 6.2% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $53.3M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.29x | Revenue / average total assets. |
| Fixed asset turnover | 1.73x | Revenue / average property, plant and equipment. |
| Inventory turnover | 5.15x | Cost of revenue / average inventory. |
| Days inventory | 71 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 2.60x | Revenue / average receivables. |
| Days sales outstanding | 140 days | 365 x average receivables / revenue. |
| Days payables | 45 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 166 days | Days inventory + days sales outstanding - days payables. |
| FCF conversion | 34.0% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 24.8% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $0.03 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | $0.03 | Net income per basic share, as reported (split-adjusted). |
| Revenue per share | $0.27 | Revenue / diluted weighted shares. |
| FCF per share | $0.01 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $0.01 | Cash from operations / diluted weighted shares. |
| Book value per share | $0.79 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $0.73 | Tangible book value / shares outstanding. |
| Cash per share | $0.02 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $165.2M | Share price x shares outstanding. |
| Enterprise value | $163.4M | Market cap + total debt - cash - short-term investments. |
| P/E | 85.0x | Market cap / net income. Only when net income is positive. |
| P/S | 8.43x | Market cap / revenue. |
| P/B | 2.86x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 3.10x | Market cap / tangible book value, when positive. |
| P/FCF | 250x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 188x | Market cap / cash from operations, when positive. |
| EV/Sales | 8.33x | Enterprise value / revenue. |
| EV/EBIT | 67.1x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 52.4x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 247x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 0.4% | Free cash flow / market cap. |
| Earnings yield | 1.2% | Net income / market cap (the inverse of P/E). |
What was Hongli Group Inc.'s revenue in fiscal 2025?
Hongli Group Inc. reported revenue of $19.6M for fiscal 2025, 39% higher than the year before.
Was Hongli Group Inc. profitable in fiscal 2025?
Yes. Net income was $1.9M, a net margin of 9.9%.
How much free cash flow did Hongli Group Inc. generate in fiscal 2025?
Cash from operations of $878.3K minus capital expenditures of $217.4K left free cash flow of $660.8K.